iSpecimen

iSpecimen Capital Intensity

The Capital Intensity Ratio of iSpecimen (ISPC) as of Nov 18, 2026 is 494.11 %. In the previous year, Capital Intensity Ratio was 100.64 % — a change of 390.99% (higher).

Capital Intensity

494.11 %

YoY

390.99%

Last updated:

Capital Intensity Ratio of iSpecimen is 2025 494.11 % . Capital Intensity Ratio of iSpecimen was 2024 100.64 % . It decreases by 390.99% higher compared to the previous year.

The iSpecimen Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
92.03 USD
Jan 1, 2019
98.05 USD
Jan 1, 2020
75.88 USD
Jan 1, 2021
320.78 USD
Jan 1, 2022
236.66 USD
Jan 1, 2023
159.34 USD
Jan 1, 2024
100.64 USD
Jan 1, 2025
494.11 USD
The iSpecimen Capital Intensity history
YEARCapital IntensityYoY
494.11 %+390.99%
100.64 %-36.84%
159.34 %-32.67%
236.66 %-26.22%
320.78 %+322.77%
75.88 %-22.62%
98.05 %+6.54%
92.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iSpecimen Stock analysis

What does iSpecimen do? iSpecimen, Inc. generates revenue through its iSpecimen Marketplace platform, which connects healthcare providers with biospecimens to researchers in biopharmaceutical, in vitro diagnostic (IVD), and government/academic sectors. The platform consolidates biospecimen procurement by offering a single online marketplace where healthcare supply partners provide de-identified healthcare data, enabling researchers to search, manage workflows, and access administrative tools. Biopharmaceutical companies, IVD firms, and academic institutions purchase access to the platform’s data and services to accelerate medical discovery and streamline procurement processes. The company’s functional areas—search, workflow, data, and administration and reporting—support these transactions through integrated administrative and compliance management for all users. The iSpecimen Marketplace platform serves biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions by providing a centralized hub for biospecimen procurement. Healthcare providers supplying biospecimens use the platform to list their collections, while researchers from the target sectors access the data for their studies. The platform’s de-identified healthcare data, compiled from healthcare supply partners, is a key asset that drives transactions. Administrative and reporting functions within the platform streamline operations for both suppliers and researchers, reducing manual effort and improving compliance. iSpecimen, Inc. monetizes its platform by facilitating connections between biospecimen suppliers and researchers across biopharmaceutical, IVD, and academic sectors. The company’s revenue comes from transactions and services provided through the iSpecimen Marketplace, which includes search capabilities, workflow management, data access, and administrative support. Healthcare supply partners contribute de-identified healthcare data to the platform, which researchers use to identify and procure necessary biospecimens for medical research and development. iSpecimen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iSpecimen stock

Capital Intensity Ratio of iSpecimen is 494.11 % in 2025.

Capital Intensity Ratio of iSpecimen changed from 100.64 % to 494.11 %, representing a 390.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio iSpecimen since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's iSpecimen with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — iSpecimen

All Key Metrics — iSpecimen